The Defense Health Agency (DHA) issued a Sources Sought notification seeking vendors to establish a Qualified Suppliers Listing (QSL) for Pulse Oximeter-Fingertip (Non-Aeromedical Certified) devices. This initiative aims to standardize medical equipment used by Military Treatment Facilities (MTFs) across the armed forces, with a projected annual sales volume of approximately $107,760. Interested vendors must complete a QSL Package Worksheet by March 13, 2025, which includes detailed company and product information, documented compliance with FDA regulations, and evidence that their products meet specific performance requirements, such as dimensions, power source, and operational features. Eligible vendors, who must have a Defense Medical Materiel (DMM) number and a Distribution and Pricing Agreement (DAPA), will be invited to submit pricing quotes around May 8, 2025. All items must be produced in compliance with the Trade Agreements Act (TAA) and should not include natural rubber latex. This process highlights the government’s effort to streamline procurement while ensuring compliance with health and safety standards.
This document outlines the requirements for vendors to qualify for the Qualified Suppliers List (QSL) related to the Department of Defense (DoD) Medical/Surgical Prime Vendor Program. Key requirements include the need for vendors to possess a Defense Logistics Agency Activity (DAPA) number, an agreement with DoD’s current Medical/Surgical Prime Vendors, and an active registration in the System for Award Management (SAM) with a valid CAGE Code. The primary product specified is a Pulse Oximeter-Fingertip (Non-Aeromedical Certified), for which vendors must provide detailed product specifications, including manufacturer part numbers, compliance with FDA regulations, and information on product materials, such as the exclusion of natural rubber latex. Supporting documentation and product literature are essential for each item submitted. The document emphasizes strict adherence to compliance deadlines and the submission of complete and accurate responses to avoid disqualification. It serves as a formal solicitation for proposals from potential vendors wishing to participate in supplying these medical products for military use, aligning with federal procurement protocols.